(Q80821601)

English

Safety and tolerability of velafermin (CG53135-05) in patients receiving high-dose chemotherapy and autologous peripheral blood stem cell transplant

scientific article published on 21 August 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17710442%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Safety and tolerability of velafermin (CG53135-05) in patients receiving high-dose chemotherapy and autologous peripheral blood stem cell transplant (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17710442%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference

based on heuristic

inferred from title

stem cell transplantation

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17710442%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

author name string

Michael W Schuster

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17710442%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

John G Harpel

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17710442%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

June Greenberg

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17710442%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Bita Jalilizeinali

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17710442%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Scott Possley

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17710442%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Robert W Gerwien

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17710442%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

William Hahne

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17710442%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Yuan-Di C Halvorsen

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17710442%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

publication date

21 August 2007

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17710442%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Supportive Care in Cancer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17710442%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17710442%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17710442%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

477-483

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17710442%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

https://scigraph.springernature.com/pub.10.1007/s00520-007-0325-9

0 references

Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17710442

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Single-Dose Prevention or Short-Term Treatment with Fibroblast Growth Factor-20 (CG53135-05)Reduces the Severity and Duration of Oral Mucositis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17710442

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A novel human fibroblast growth factor treats experimental intestinal inflammation

1 reference

https://pubmed.ncbi.nlm.nih.gov/17710442

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanisms underlying differential responses to FGF signaling

1 reference

https://pubmed.ncbi.nlm.nih.gov/17710442

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcome of local application of amifostine (WR-1065) on epirubicin-induced oral mucositis. A phase II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17710442

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduction of oral mucositis by filgrastim (r-metHuG-CSF) in patients receiving chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17710442

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective randomised trial of amifostine cytoprotection in myeloma patients undergoing high-dose melphalan conditioned autologous stem cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/17710442

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preclinical characterization of CG53135 (FGF-20) in radiation and concomitant chemotherapy/radiation-induced oral mucositis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17710442

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

FGF-20 and DKK1 are transcriptional targets of beta-catenin and FGF-20 is implicated in cancer and development

1 reference

https://pubmed.ncbi.nlm.nih.gov/17710442

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mucosal damage: a major risk factor for severe complications after cytotoxic therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17710442

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amifostine reduces mucosal damage after high-dose melphalan conditioning and autologous peripheral blood progenitor cell transplantation for patients with multiple myeloma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17710442

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase III, randomized, double-blind, placebo-controlled, study of iseganan for the reduction of stomatitis in patients receiving stomatotoxic chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17710442

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17710442

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of a novel human fibroblast growth factor and characterization of its role in oncogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17710442

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescue

1 reference

https://pubmed.ncbi.nlm.nih.gov/17710442

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The economic burden of supportive care of cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17710442

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized Phase I Trial of Recombinant Human Keratinocyte Growth Factor Plus Chemotherapy: Potential Role as Mucosal Protectant

1 reference

https://pubmed.ncbi.nlm.nih.gov/17710442

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Palifermin for oral mucositis after intensive therapy for hematologic cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/17710442

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00520-007-0325-9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17710442%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17710442%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q80821601&oldid=2125047892"